GlassScriptPhysician profile
Cassidy Starling
NPI 1356055172
$719.96
in general payments reported to CMS, 2019-2025
7 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $349 · 2024: $171 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663 · Entertainment: $56.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.49 |
| Entertainment | $56.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $238.23 | 2023-2025 | Lotemax Sm, Vyzulta, Infuse |
| Oyster Point Pharma, INC. | $135.01 | 2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $100.00 | 2024 | Acuvue |
| Rxsight INC | $100.00 | 2023 | Rxsight Injector Handpiece, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $75.60 | 2025 | Oxervate |
| Optos, INC. | $56.47 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $14.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassidy Starling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.